|
||
Articles |





Department of Physiology, the
Department of Geriatrics, and the || Department of Disease-related Gene Regulation Research (Sandoz), Faculty of Medicine, The University of Tokyo, Tokyo 113, Japan; and the ¶ Pharmaceutical Basic Research Laboratories (Aobadai), Japan Tobacco Inc., Kanagawa 227, Japan
Platelet-activating factor (PAF) is a potent phospholipid mediator with diverse biological activities in addition to its well-known ability to stimulate platelet aggregation. Pharmacologic studies had suggested a role for PAF in pregnancy, neuronal cell migration, anaphylaxis, and endotoxic shock. Here we show that disruption of the PAF receptor gene in mice caused a marked reduction in systemic anaphylactic symptoms. Unexpectedly, however, the PAF receptor–deficient mice developed normally, were fertile, and remained sensitive to bacterial endotoxin. These mutant mice clearly show that PAF plays a dominant role in eliciting anaphylaxis, but that it is not essential for reproduction, brain development, or endotoxic shock.
Key Words: platelet-activating factor platelet-activating factor receptor anaphylaxis endotoxic shock gene targeting
Abbreviations used: ANOVA, analysis of variance; ES, embryonic stem; HR, heart rate; LTB4, leukotriene B4; MAP, mean arterial pressure; NO, nitric oxide; PAF, platelet-activating factor; RL, total lung resistance.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
| TABLE OF CONTENTS |
|